Heron TherapeuticsHRTX
那斯達克 · USD
0.30
+0.03
(+9.26%)
盤中 09/23 12:52 (UTC+8)
09/23 12:52 (UTC+8)
Heron TherapeuticsHRTX
0.30
+0.03
(+9.26%)
財務數據
損益表
- 0.35
- 0.36
- 0.33
- 0.41
- 0.39
- 0.37
- 0.38
- 0.41
- 0.35
- 0.38
- 1.28
- 3.91
- -8.92
- 24.29
- -4.61
- -4.38
- 2.72
- 6.22
- -14.48
- 8.51
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 37,666 | 34,711 | 40,588 | 38,213 | 37,200 | 38,903 | 40,781 | 32,810 | 36,024 | 34,670 |
營業成本 | 11,572 | 10,638 | 11,119 | 11,914 | 9,857 | 8,457 | 10,228 | 9,458 | 10,518 | 8,444 |
營業毛利 | 26,094 | 24,073 | 29,469 | 26,299 | 27,343 | 30,446 | 30,553 | 23,352 | 25,506 | 26,226 |
營業費用 | 28,138 | 28,838 | 29,431 | 30,392 | 28,980 | 27,292 | 26,380 | 27,810 | - | 31,024 |
研發費用 | 2,702 | 2,385 | 3,746 | 3,470 | 2,934 | 2,279 | 3,178 | 4,465 | 4,432 | 4,608 |
推銷及管理費用 | 25,436 | 26,453 | 25,685 | 26,922 | 26,046 | 25,013 | 23,202 | 23,345 | 27,519 | 26,416 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -2,044 | -4,765 | 38 | -4,093 | -1,637 | 3,154 | 4,173 | -4,458 | -6,445 | -4,798 |
其他收入及費用 | -3,445 | -3,346 | 6,613 | -13,402 | -744 | -519 | 5,522 | -390 | -2,790 | 1,638 |
利息費用 | - | - | 9,605 | - | - | - | 6,032 | - | - | - |
稅前純益 | -5,489 | -8,111 | -2,954 | -17,495 | -2,381 | 2,635 | 3,663 | -4,848 | -9,235 | -3,160 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -5,489 | -8,111 | -2,954 | -17,495 | -2,381 | 2,635 | 3,663 | -4,848 | -9,235 | -3,160 |
基本每股稅後盈餘(元) | -0.03 | -0.04 | -0.02 | -0.10 | -0.02 | 0.02 | 0.02 | -0.03 | -0.06 | -0.02 |
稀釋每股稅後盈餘(元) | -0.03 | -0.04 | -0.01 | -0.10 | -0.02 | 0.01 | 0.02 | -0.03 | -0.06 | -0.02 |
基本平均股數(千股) | 190335.00 | 189646.00 | 188031.00 | 170348.00 | 154020.00 | 153490.00 | 153151.00 | 152830.00 | 152305.00 | 158000.00 |
稀釋平均股數(千股) | 190335.00 | 189646.00 | 188031.00 | 170348.00 | 154020.00 | 196921.00 | 153151.00 | 152830.00 | 152305.00 | 158000.00 |
還原基本每股稅後盈餘(元) | -0.03 | -0.04 | -0.02 | -0.10 | -0.02 | 0.02 | 0.02 | -0.03 | -0.06 | -0.02 |
還原稀釋每股稅後盈餘(元) | -0.03 | -0.04 | -0.01 | -0.10 | -0.02 | 0.01 | 0.02 | -0.03 | -0.06 | -0.02 |
還原基本平均股數(千股) | 190,335 | 189,646 | 188,031 | 170,348 | 154,020 | 153,490 | 153,151 | 152,830 | 152,305 | 158,000 |
還原稀釋平均股數(千股) | 190,335 | 189,646 | 188,031 | 170,348 | 154,020 | 196,921 | 153,151 | 152,830 | 152,305 | 158,000 |
EBITDA(千元) | -4,961 | -7,506 | 7,303 | -16,814 | -1,803 | 3,116 | 10,187 | -4,433 | -9,023 | -2,969 |